Nazaire Mangani Nseka
Overview
Explore the profile of Nazaire Mangani Nseka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mbadu Lelo S, Musungayi Kajingulu F, Makulo J, Mayamba Nlandu Y, Bukabau J, Koso Mbulupasu P, et al.
Int J Nephrol Renovasc Dis
. 2024 Feb;
17:71-79.
PMID: 38405026
Background: Data on 25 [OH] vitamin D and intact parathyroid hormone [iPTH] in hemodialysis patients are very limited in sub-Saharan African countries. The present study aimed to assess the magnitude...
2.
Musungayi Kajingulu F, Lepira F, Nkodila A, Makulo J, Momeme Mokoli V, Ekulu P, et al.
BMC Nephrol
. 2022 Mar;
23(1):123.
PMID: 35354429
Background: Cardiovascular (CV) disease is the leading cause of mortality in patients with end-stage kidney disease (ESKD). The aim of the present study was to determine whether Proprotein Convertase Subtilisin/Kexin...
3.
Musungayi Kajingulu F, Lepira F, Nkodila A, Makulo J, Momeme Mokoli V, Ekulu P, et al.
Rambam Maimonides Med J
. 2021 Jul;
12(3).
PMID: 34270402
Context And Objective: Cardiovascular diseases are the leading cause of mortality in patients. In this context, proprotein convertase subtilisin/kexin type 9 (PCSK9) appears to be the new biomarker identified as...
4.
Mayamba Nlandu Y, Makulo J, Nkondi C, Engole Y, Sumaili E, Mangani Nseka N
Transplantation
. 2021 Mar;
105(4):677-678.
PMID: 33760785
No abstract available.
5.
Engole Y, Lepira F, Mayamba Nlandu Y, Lubenga Y, Nkondi C, Luzayadio Longo A, et al.
Rambam Maimonides Med J
. 2021 Jan;
12(1).
PMID: 33478626
Objective: Early identification of atherosclerosis using a non-invasive tool like ankle-brachial index (ABI) could help reduce the risk for cardiovascular disease among long-term hemodialysis patients. The study objective was to...
6.
Engole Y, Lepira F, Mayamba Nlandu Y, Lubenga Y, Luzayadio Longo A, Nkodila A, et al.
BMC Nephrol
. 2020 Nov;
21(1):460.
PMID: 33148221
Background: Although cardiovascular diseases in particular Pulmonary Arterial Hypertension (PAH) is associated with, high morbid-mortality in chronic hemodialysis, but its magnitude remains paradoxically unknown in sub-Saharan Africa. The aim of...
7.
Momeme Mokoli V, Sumaili E, Lepira F, Ikwa Ndol Mbutiwi F, Makulo J, Bukabau J, et al.
BMC Nephrol
. 2018 Mar;
19(1):68.
PMID: 29554877
Background: Decreased residual urine volume (RUV) is associated with higher mortality in hemodialysis (HD). However, few studies have examined RUV in patients on HD in Sub-Saharan Africa. The aim of...
8.
Aloni M, Ngiyulu R, Ekulu P, Mbutiwi F, Makulo J, Gini-Ehungu J, et al.
Acta Paediatr
. 2017 Feb;
106(5):819-824.
PMID: 28218952
Aim: Glomerular hyperfiltration is an early marker of sickle cell nephropathy and can lead to microalbuminuria and renal failure. Our aim was to identify the associated risk factors, as these...
9.
Aloni M, Ngiyulu R, Nsibu C, Ekulu P, Makulo J, Gini-Ehungu J, et al.
J Clin Lab Anal
. 2017 Jan;
31(6).
PMID: 28102613
Background: The prevalence of sickle cell trait is extremely high in sub-Saharan Africa. Recent studies have reported the impact of sickle cell carriers on renal function. However, data on renal...
10.
Impact of residual urine volume decline on the survival of chronic hemodialysis patients in Kinshasa
Momeme Mokoli V, Sumaili E, Lepira F, Makulo J, Bukabau J, Osa Izeidi P, et al.
BMC Nephrol
. 2016 Nov;
17(1):182.
PMID: 27871253
Background: Despite the multiple benefits of maintaining residual urine volume (RUV) in hemodialysis (HD), there is limited data from Sub-Saharan Africa. The aim of this study was to assess the...